These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 16320053)
1. C-kit receptor tyrosine kinase (CD117) expression and its positive predictive value for the diagnosis of Thai adult acute myeloid leukemia. Auewarakul CU; Lauhakirti D; Promsuwicha O; Munkhetvit C Ann Hematol; 2006 Feb; 85(2):108-12. PubMed ID: 16320053 [TBL] [Abstract][Full Text] [Related]
2. Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia. Hans CP; Finn WG; Singleton TP; Schnitzer B; Ross CW Am J Clin Pathol; 2002 Feb; 117(2):301-5. PubMed ID: 11863227 [TBL] [Abstract][Full Text] [Related]
3. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia]. Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262 [TBL] [Abstract][Full Text] [Related]
4. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype. Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721 [TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of CD117/CD34 co-expression in adult patients with acute leukemia]. Shi H; Zhu F; Xiao AQ; Zhang ZR; Zhang R Ai Zheng; 2006 Jun; 25(6):762-4. PubMed ID: 16764777 [TBL] [Abstract][Full Text] [Related]
6. CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T/myeloid acute leukemia. Hoehn D; Medeiros LJ; Chen SS; Tian T; Jorgensen JL; Ahmed Y; Lin P Am J Clin Pathol; 2012 Feb; 137(2):213-9. PubMed ID: 22261446 [TBL] [Abstract][Full Text] [Related]
7. Importance of CD117 in the evaluation of acute leukemias by flow cytometry. Newell JO; Cessna MH; Greenwood J; Hartung L; Bahler DW Cytometry B Clin Cytom; 2003 Mar; 52(1):40-3. PubMed ID: 12599181 [TBL] [Abstract][Full Text] [Related]
8. Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies. Graf M; Reif S; Hecht K; Kroell T; Nuessler V; Schmetzer H Eur J Haematol; 2005 Dec; 75(6):477-84. PubMed ID: 16313259 [TBL] [Abstract][Full Text] [Related]
9. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia. Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229 [TBL] [Abstract][Full Text] [Related]
10. c-Kit receptor (CD117) expression on myeloblasts and white blood cell counts in acute myeloid leukemia. Woźniak J; Kopeć-Szlezak J Cytometry B Clin Cytom; 2004 Mar; 58(1):9-16. PubMed ID: 14994370 [TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies. Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246 [TBL] [Abstract][Full Text] [Related]
12. KIT and FLT3 receptor tyrosine kinase mutations in acute myeloid leukemia with favorable cytogenetics: two novel mutations and selective occurrence in leukemia subtypes and age groups. Sritana N; Auewarakul CU Exp Mol Pathol; 2008 Dec; 85(3):227-31. PubMed ID: 18977345 [TBL] [Abstract][Full Text] [Related]
13. [Immunologic characteristics and prognosis of acute myeloid leukemia M1]. Zhao F; Chen Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783 [TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic profile predictive of KIT activating mutations in AML1-ETO leukemia. De J; Zanjani R; Hibbard M; Davis BH Am J Clin Pathol; 2007 Oct; 128(4):550-7. PubMed ID: 17875504 [TBL] [Abstract][Full Text] [Related]
15. [Analysis of CD117 expression on leukemia cells]. Shen HQ; Tang YM; Yang SL; Qian BQ; Song H; Shi SW; Xu WQ Zhonghua Xue Ye Xue Za Zhi; 2003 May; 24(5):228-30. PubMed ID: 12859870 [TBL] [Abstract][Full Text] [Related]
16. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia. Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043 [TBL] [Abstract][Full Text] [Related]
17. CD117/CD34 expression in leukemic blasts. Wells SJ; Bray RA; Stempora LL; Farhi DC Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172 [TBL] [Abstract][Full Text] [Related]
18. C-kit receptor expression in acute leukemias-association with patient and disease characteristics and with outcome. Tsao AS; Kantarjian H; Thomas D; Giles F; Cortes J; Garcia-Manero G; Huh Y; Yang Y; Shen Y; Albitar M; Estey E Leuk Res; 2004 Apr; 28(4):373-8. PubMed ID: 15109537 [TBL] [Abstract][Full Text] [Related]
19. CD34/CD117 positivity in assessment of prognosis in children with myelodysplastic syndrome. Tavil B; Cetin M; Tuncer M Leuk Res; 2006 Feb; 30(2):222-4. PubMed ID: 16098587 [TBL] [Abstract][Full Text] [Related]
20. Enhanced myeloid specificity of CD117 compared with CD13 and CD33. Nomdedéu JF; Mateu R; Altès A; Llorente A; Rio C; Estivill C; López O; Ubeda J; Rubiol E Leuk Res; 1999 Apr; 23(4):341-7. PubMed ID: 10229319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]